Copenhagen Biotech Traitomic Secures €20 Million Series A to Expand Trait Discovery Platform Globally
Copenhagen‑based biotech spin‑out Traitomic raised €20 million in a Series A led by Sofinnova Partners to commercialise its non‑gene‑edited trait discovery platform, expand internationally and broaden its services.